The role of economic analyses in promoting adoption of behavioral and psychosocial interventions in clinical settings.


Journal

Health psychology : official journal of the Division of Health Psychology, American Psychological Association
ISSN: 1930-7810
Titre abrégé: Health Psychol
Pays: United States
ID NLM: 8211523

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 13 11 2019
Statut: ppublish

Résumé

In this report, we offer three examples of how economic data could promote greater adoption of behavioral and psychosocial interventions in clinical settings where primary or specialty medical care is delivered to patients. The examples are collaborative care for depression, chronic pain management, and cognitive-behavioral therapy for insomnia. These interventions illustrate differences in the availability of cost and cost-effectiveness data and in the extent of intervention adoption and integration into routine delivery of medical care. Collaborative care has been widely studied from an economic perspective, with most studies demonstrating its relative cost-effectiveness per quality-adjusted life year (QALY) and some studies demonstrating its potential for cost neutrality or cost savings. The success of collaborative care for depression can be viewed as a model for how to promote greater adoption of other interventions, such as psychological therapies for chronic pain and insomnia. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Identifiants

pubmed: 31368752
pii: 2019-44318-004
doi: 10.1037/hea0000774
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

680-688

Auteurs

Paul B Jacobsen (PB)

Division of Cancer Control and Population Sciences, National Cancer Institute.

Ravi Prasad (R)

Department of Anesthesiology and Pain Medicine, School of Medicine, University of California, Davis.

Jennifer Villani (J)

Office of Disease Prevention, National Institutes of Health.

Chuan-Mei Lee (CM)

Stanford School of Medicine Clinical Excellence Research Center.

Danielle Rochlin (D)

Stanford School of Medicine Clinical Excellence Research Center.

Claudia Scheuter (C)

Stanford School of Medicine Clinical Excellence Research Center.

Robert M Kaplan (RM)

Stanford School of Medicine Clinical Excellence Research Center.

Kenneth E Freedland (KE)

Department of Psychiatry, Washington University School of Medicine.

Rachel Manber (R)

Stanford Neurosciences Institute, Stanford University.

Jubran Kanaan (J)

Economic and Regulatory Services, ICF.

Dawn K Wilson (DK)

Department of Psychology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH